241 related articles for article (PubMed ID: 28481868)
41. PIN1 facilitates ubiquitin-mediated degradation of serine/threonine kinase 3 and promotes melanoma development via TAZ activation.
Kim G; Bhattarai PY; Lim SC; Kim JY; Choi HS
Cancer Lett; 2021 Feb; 499():164-174. PubMed ID: 33253791
[TBL] [Abstract][Full Text] [Related]
42. H-Ras induces Nrf2-Pin1 interaction: Implications for breast cancer progression.
Saeidi S; Kim SJ; Han HJ; Kim SH; Zheng J; Lee HB; Han W; Noh DY; Na HK; Surh YJ
Toxicol Appl Pharmacol; 2020 Sep; 402():115121. PubMed ID: 32621833
[TBL] [Abstract][Full Text] [Related]
43. Prolyl isomerase Pin1 promotes proplatelet formation of megakaryocytes via tau.
Shimizu T; Uchida C; Shimizu R; Motohashi H; Uchida T
Biochem Biophys Res Commun; 2017 Nov; 493(2):946-951. PubMed ID: 28943044
[TBL] [Abstract][Full Text] [Related]
44. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults.
Zacchi P; Gostissa M; Uchida T; Salvagno C; Avolio F; Volinia S; Ronai Z; Blandino G; Schneider C; Del Sal G
Nature; 2002 Oct; 419(6909):853-7. PubMed ID: 12397362
[TBL] [Abstract][Full Text] [Related]
45. The PIN1-YTHDF1 axis promotes breast tumorigenesis via the m
Shrestha P; Kim G; Kang H; Bhattarai PY; Choi HS
Arch Pharm Res; 2024 Jan; 47(1):66-81. PubMed ID: 38147203
[TBL] [Abstract][Full Text] [Related]
46. Peptidyl-prolyl isomerase 1 (Pin1) preserves the phosphorylation state of tissue factor and prolongs its release within microvesicles.
Ettelaie C; Collier MEW; Featherby S; Greenman J; Maraveyas A
Biochim Biophys Acta Mol Cell Res; 2018 Jan; 1865(1):12-24. PubMed ID: 28962834
[TBL] [Abstract][Full Text] [Related]
47. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC.
Ryo A; Nakamura M; Wulf G; Liou YC; Lu KP
Nat Cell Biol; 2001 Sep; 3(9):793-801. PubMed ID: 11533658
[TBL] [Abstract][Full Text] [Related]
48. PIN1P1 is activated by CREB1 and promotes gastric cancer progression via interacting with YBX1 and upregulating PIN1.
Wang YW; Zhu WJ; Ma RR; Tian YR; Chen X; Gao P
J Cell Mol Med; 2024 Jan; 28(1):e18022. PubMed ID: 37929660
[TBL] [Abstract][Full Text] [Related]
49. Binding and regulation of the transcription factor NFAT by the peptidyl prolyl cis-trans isomerase Pin1.
Liu W; Youn HD; Zhou XZ; Lu KP; Liu JO
FEBS Lett; 2001 May; 496(2-3):105-8. PubMed ID: 11356192
[TBL] [Abstract][Full Text] [Related]
50. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.
Lee NY; Choi HK; Shim JH; Kang KW; Dong Z; Choi HS
Carcinogenesis; 2009 Apr; 30(4):671-81. PubMed ID: 19168580
[TBL] [Abstract][Full Text] [Related]
51. The peptidyl-isomerase Pin1 regulates p27kip1 expression through inhibition of Forkhead box O tumor suppressors.
Brenkman AB; de Keizer PL; van den Broek NJ; van der Groep P; van Diest PJ; van der Horst A; Smits AM; Burgering BM
Cancer Res; 2008 Sep; 68(18):7597-605. PubMed ID: 18794148
[TBL] [Abstract][Full Text] [Related]
52. Dual function of Pin1 in NR4A nuclear receptor activation: enhanced activity of NR4As and increased Nur77 protein stability.
van Tiel CM; Kurakula K; Koenis DS; van der Wal E; de Vries CJ
Biochim Biophys Acta; 2012 Oct; 1823(10):1894-904. PubMed ID: 22789442
[TBL] [Abstract][Full Text] [Related]
53. Pin1 contributes to cervical tumorigenesis by regulating cyclin D1 expression.
Li H; Wang S; Zhu T; Zhou J; Xu Q; Lu Y; Ma D
Oncol Rep; 2006 Sep; 16(3):491-6. PubMed ID: 16865248
[TBL] [Abstract][Full Text] [Related]
54. TNFα reduces eNOS activity in endothelial cells through serine 116 phosphorylation and Pin1 binding: Confirmation of a direct, inhibitory interaction of Pin1 with eNOS.
Kennard S; Ruan L; Buffett RJ; Fulton D; Venema RC
Vascul Pharmacol; 2016 Jun; 81():61-8. PubMed ID: 27073025
[TBL] [Abstract][Full Text] [Related]
55. Structural Analysis of the Pin1-CPEB1 interaction and its potential role in CPEB1 degradation.
Schelhorn C; Martín-Malpartida P; Suñol D; Macias MJ
Sci Rep; 2015 Oct; 5():14990. PubMed ID: 26456073
[TBL] [Abstract][Full Text] [Related]
56. Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 as a molecular target in breast cancer: a therapeutic perspective of gynecological cancer.
Kim G; Bhattarai PY; Choi HS
Arch Pharm Res; 2019 Feb; 42(2):128-139. PubMed ID: 30684192
[TBL] [Abstract][Full Text] [Related]
57. Dynamic regulation of Pin1 expression and function during zebrafish development.
Ibarra MS; Borini Etichetti C; Di Benedetto C; Rosano GL; Margarit E; Del Sal G; Mione M; Girardini J
PLoS One; 2017; 12(4):e0175939. PubMed ID: 28426725
[TBL] [Abstract][Full Text] [Related]
58. Pin1 gene mutation is a rare event in gastric cancer.
Kim CJ; Song JH; Cho YG; Chae HS; Nam SW; Yoo NJ; Lee JY; Park WS
APMIS; 2006; 114(7-8):518-22. PubMed ID: 16907857
[TBL] [Abstract][Full Text] [Related]
59. Pin1 coordinates HDAC6 upregulation with cell migration in lung cancer cells.
Chuang HH; Hsu JF; Chang HL; Wang PH; Wei PJ; Wu DW; Huang MS; Hsiao M; Yang CJ
Int J Med Sci; 2020; 17(17):2635-2643. PubMed ID: 33162791
[TBL] [Abstract][Full Text] [Related]
60. Phosphorylation-specific peptidyl-prolyl isomerization of neuronal cytoskeletal proteins by Pin1: implications for therapeutics in neurodegeneration.
Rudrabhatla P; Pant HC
J Alzheimers Dis; 2010; 19(2):389-403. PubMed ID: 20110589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
